Posted by Michael Wonder on 25 Sep 2019
China’s drug price cuts pressure Lipitor and other foreign pills
24 September 2019 - Government is changing the way it procures generic drugs.
China’s plan to slash the price of many widely used drugs is pressuring large pharmaceutical companies that have long viewed the country as a place where they could make fat margins on older products.
Global drug makers including AstraZeneca Pfizer and Mylan are facing the prospect of having to cut prices in half to maintain their sales to China’s biggest public hospitals, as the country’s aggressive health-care cost control campaign gains speed.
